Summaries

AdobeStock_393558874

NICE guideline

NICE COVID-19 management

2021-09-08T08:00:00+01:00By

Summary of NICE guidance on the management of COVID-19 in children, young people, and adults in primary care settings

AdobeStock_340703775

PHE/DH/DWP guideline

PHE management of staff exposure to COVID-19

2021-09-01T10:25:00+01:00By

This summary provides guidance on the management of staff according to COVID-19 exposures, symptoms, and test results

AdobeStock_335029203

PHE/DH/DWP guideline

PHE COVID-19 infection prevention and control guidance

2021-08-20T10:30:00+01:00By

Summary of the latest UK guidance on infection prevention and control measures for COVID-19

Syringe with vaccine_AS resized

PHE/DH/DWP guideline

PHE COVID-19 vaccination guidance

2021-08-12T08:30:00+01:00By

A concise summary of guidance for healthcare professionals about the COVID-19 vaccination programme

AdobeStock_292279272

NICE guideline

COVID-19 rapid guideline on gastrointestinal and liver conditions affecting immune response

2021-04-13T13:57:00+01:00By

A summary of guidance intended to maximise the safety of children and adults with gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic

AdobeStock_287082164

NICE guideline

COVID-19 rapid guideline on dermatological conditions

2021-04-13T13:49:00+01:00By

The purpose of this Guidelines summary is to maximise the safety of children and adults who have dermatological conditions treated with drugs affecting the immune response during the COVID-19 pandemic

AdobeStock_162937550

NICE guideline

COVID-19 guideline on rheumatological autoimmune, inflammatory, and metabolic bone disorders

2021-04-09T15:27:00+01:00By

This guideline aims to maximise the safety of children and adults with rheumatological autoimmune, inflammatory, and metabolic bone disorders during the COVID-19 pandemic

AdobeStock_319718852

NICE guideline

COVID-19 rapid guideline on systemic anticancer treatments

2021-02-18T11:53:00+00:00By

This summary aims to maximise the safety of patients with cancer and make the best use of NHS resources, while protecting staff from infection

AdobeStock_133646819

Independent professional body guideline

HEART UK Managing hyperlipidaemia and COVID-19

2021-02-17T14:44:00+00:00By HEART UK

A summary of collated current evidence surrounding the safety of lipid-lowering medications in patients who have COVID-19

AdobeStock_329035023

NICE guideline

NICE ‘long COVID’ guideline

2020-12-18T13:56:00+00:00By , , Royal College of General Practitioners

Recommendations for identifying and managing ‘long-COVID’ in primary care

Nurse writing notes_AS resized

NHS guideline

NHS England COVID-19 guidance for community pharmacy

2020-10-30T08:30:00+00:00By NHS England and NHS Improvement

This standard operating procedure summary sets out general principles for the delivery of services during the COVID-19 pandemic, and requires local interpretation

Pills + magnifying glass

NHS guideline

NHS guidance on NSAIDs in COVID-19

2020-06-26T12:57:00+01:00By NHS England

This summary sets out the clinical policy for the acute use of non-steroidal anti-inflammatory drugs (NSAIDs) in people with or at risk of COVID-19.

AdobeStock_332747243

NICE guideline

COVID-19 rapid guideline on COPD

2020-04-17T17:02:00+01:00By

The purpose of this summary is to maximise the safety of patients with chronic obstructive pulmonary disease (COPD) during the COVID-19 pandemic, while protecting staff from infection. It will also enable services to make the best use of NHS resources. For more detailed information, please refer to the full guideline.

AdobeStock_289304487

NICE guideline

COVID-19 rapid guideline on severe asthma

2020-04-17T13:39:00+01:00By

The purpose of this guideline is to maximise the safety of adults and children with severe asthma during the COVID-19 pandemic, while protecting staff from infection. It will also enable services to make the best use of NHS resources.